119 related articles for article (PubMed ID: 16497631)
1. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers.
Ahmed MH
Scand J Gastroenterol; 2006 Mar; 41(3):372. PubMed ID: 16497631
[No Abstract] [Full Text] [Related]
2. Are non-invasive tests accurate enough to predict hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)?
Chavez-Tapia NC; Tiribelli C
Gut; 2008 Oct; 57(10):1351-3. PubMed ID: 18791116
[No Abstract] [Full Text] [Related]
3. Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats.
Murayama H; Ikemoto M; Nagata A
J Gastroenterol Hepatol; 2009 Feb; 24(2):270-7. PubMed ID: 18823438
[TBL] [Abstract][Full Text] [Related]
4. [Non-alcoholic fatty liver].
Zwimpfer J
Praxis (Bern 1994); 2000 Oct; 89(43):1757-8. PubMed ID: 11103621
[No Abstract] [Full Text] [Related]
5. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
Pagadala M; Zein CO; McCullough AJ
Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.
Wieckowska A; McCullough AJ; Feldstein AE
Hepatology; 2007 Aug; 46(2):582-9. PubMed ID: 17661414
[TBL] [Abstract][Full Text] [Related]
7. [When should liver biopsy be considered? Slightly increased ALAT can indicate steatosis--but a histological test is necessary for prognosis].
Danielsson A
Lakartidningen; 2004 Sep; 101(38):2862. PubMed ID: 15485168
[No Abstract] [Full Text] [Related]
8. Metabolic disturbances in non-alcoholic fatty liver disease.
Byrne CD; Olufadi R; Bruce KD; Cagampang FR; Ahmed MH
Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
[TBL] [Abstract][Full Text] [Related]
9. [On the clinical picture of fatty degeneration of the liver and fatty liver].
Teichmann W; Lindemann A
Z Gesamte Inn Med; 1967 Sep; 22(17):509-14. PubMed ID: 5591413
[No Abstract] [Full Text] [Related]
10. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The other face of the coin of histology.
Ahmed MH
Med Hypotheses; 2006; 66(3):679-80. PubMed ID: 16289367
[No Abstract] [Full Text] [Related]
11. Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis.
Ayala I; Castillo AM; Adánez G; Fernández-Rufete A; Pérez BG; Castells MT
Exp Biol Med (Maywood); 2009 Jan; 234(1):10-6. PubMed ID: 18997102
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis.
Satapathy SK; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
J Gastroenterol Hepatol; 2007 May; 22(5):634-8. PubMed ID: 17444848
[TBL] [Abstract][Full Text] [Related]
13. Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore.
Chow WC; Tai ES; Lian SC; Tan CK; Sng I; Ng HS
Singapore Med J; 2007 Aug; 48(8):752-7. PubMed ID: 17657385
[TBL] [Abstract][Full Text] [Related]
14. Problems with NASH? HAIR is some help.
Phillips H; Balart LA
Am J Gastroenterol; 2003 Feb; 98(2):500. PubMed ID: 12591077
[No Abstract] [Full Text] [Related]
15. [Laboratory data for assessment of nutrition in liver disease--with special reference to alcoholic hepatitis and nonalcoholic steatohepatitis (NASH)].
Sugimoto M
Rinsho Byori; 2003 Oct; Suppl 127():45-51. PubMed ID: 14653214
[No Abstract] [Full Text] [Related]
16. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
[TBL] [Abstract][Full Text] [Related]
17. [Fatty hepatosis. Non-alcoholic steatohepatitis (evolution of the knowledge about clinico-morphological features, prognosis, treatment)].
Podymova SD
Ter Arkh; 2006; 78(4):32-8. PubMed ID: 16821419
[TBL] [Abstract][Full Text] [Related]
18. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
Ali R; Cusi K
Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
[TBL] [Abstract][Full Text] [Related]
19. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
20. Magic angle spinning magnetic resonance: a novel method opening up translational research into NAFLD?
Boesch C
Clin Sci (Lond); 2009 Mar; 116(5):401-2. PubMed ID: 19053946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
